ArticleJournal of innate immunity2026
Clodronate Liposomes Untangle the Role of Hemocytes in <italic>Apis mellifera</italic> Response to Temperature Variation and Microbial Infection.
Article in Journal of innate immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
6 authors.
Funding
Abstract
introductionThe cellular immune response, mediated by hemocytes, is a fundamental component of honey bee (Apis mellifera) health. However, the specific contribution of hemocyte subtypes to resilience against combined stressors remains poorly characterized. This study investigated the effect of temperature and bacterial challenge on hemocyte abundance. We employed clodronate liposomes (CLD) for the first time in honey bees as a novel tool for the selective depletion of hemocytes to investigate this gap.
methodsFive-day-old (nurses) and fifteen-day-old (foragers) honey bees were treated with CLD, control liposomes, phosphate-buffered saline, injection wound (sham), or left untreated, then exposed at either 32°C or 22°C and challenged with the Gram-negative bacterium, Escherichia coli, or the Gram-positive bacterium, Staphylococcus aureus. Survival, hemolymph volume, total hemocyte counts, and differential hemocyte counts were monitored over 7 days from the start of exposure.
resultsThe CLD application demonstrated significant reductions in granulocyte and prohemocyte populations. This indicates that the granulocytes are the phagocytic cell type and prohemocytes are probably used to replenish the granulocytes. A temperature drop to 22°C buffered the negative impact of CLD-induced immunosuppression on honey bee survival. While bacterial challenge universally reduced hemocyte counts, we found an age-dependent difference, where young maintained significantly higher baseline total hemocyte counts than older bees. Furthermore, temperature did not affect overall total hemocyte counts in 5-day-old bees but did in 15-day-old bees, where it significantly modulated the hemocyte response to bacterial infection.
conclusionOur findings show that hemocyte function is non-uniform, with specific subtypes being essential for overall resilience. The results highlight a previously underappreciated role for temperature as a key modulator of immune capacity, particularly in immunocompromised bees. The age-related decreases in hemocyte abundance, coupled with increased survival after an immune challenge, suggests a life history trade-off where older bees rely less on cellular immunity and more on other physiological mechanisms for resilience. This work establishes CLD as a powerful tool for insect immunology and sets a precedent for using precise immune manipulation to study host-pathogen-environment interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.